Cargando…

Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review

BACKGROUND: Adherence to oral chemotherapy is crucial to maximize treatment outcomes and avoid health complications in cancer patients. Mobile phones are widely available worldwide, and evidence that this technology can be successfully employed to increase medication adherence for the treatment of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrabal Ross, Xiomara, Gunn, Kate M, Patterson, Pandora, Olver, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320412/
https://www.ncbi.nlm.nih.gov/pubmed/30578182
http://dx.doi.org/10.2196/11724
_version_ 1783385220542627840
author Skrabal Ross, Xiomara
Gunn, Kate M
Patterson, Pandora
Olver, Ian
author_facet Skrabal Ross, Xiomara
Gunn, Kate M
Patterson, Pandora
Olver, Ian
author_sort Skrabal Ross, Xiomara
collection PubMed
description BACKGROUND: Adherence to oral chemotherapy is crucial to maximize treatment outcomes and avoid health complications in cancer patients. Mobile phones are widely available worldwide, and evidence that this technology can be successfully employed to increase medication adherence for the treatment of other chronic diseases (eg, diabetes) is well established. However, the extent to which there is evidence that mobile phone–based interventions improve adherence to oral chemotherapy is unknown. OBJECTIVE: This scoping review aims to explore what is known about mobile phone–delivered interventions designed to enhance adherence to oral chemotherapy, to examine the reported findings on the utility of these interventions in increasing oral chemotherapy adherence, and to identify opportunities for development of future interventions. METHODS: This study followed Arksey and O’Malley’s scoping review methodological framework. RESULTS: The review search yielded 5 studies reporting on 4 interventions with adults (aged >18 years) diagnosed with diverse cancer types. All interventions were considered acceptable, useful, and feasible. The following themes were evident: text messages and mobile apps were the main methods of delivering these interventions, the 2 most commonly employed oral chemotherapy adherence–enhancing strategies were management and reporting of drug-related symptoms and reminders to take medication, the importance of stakeholders’ engagement in intervention design, and the overall positive perceptions of delivery features. Areas for future research identified by this review include the need for further studies to evaluate the impact of mobile phone–delivered interventions on adherence to oral chemotherapy as well as the relevance for future studies to incorporate design frameworks and economic evaluations and to explore the moderator effect of high anxiety, poor baseline adherence, and longer time taking prescribed drug on adherence to oral chemotherapy. CONCLUSIONS: Despite the increasing body of evidence on the use of mobile phones to deliver medication adherence–enhancing interventions in chronic diseases, literature on the oral chemotherapy context is lacking. This review showed that existing interventions are highly acceptable and useful to cancer patients. The engagement of stakeholders as well as the use of a design framework are important elements in the development of mobile phone–delivered interventions that can be translated into oncology settings.
format Online
Article
Text
id pubmed-6320412
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-63204122019-01-28 Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review Skrabal Ross, Xiomara Gunn, Kate M Patterson, Pandora Olver, Ian JMIR Mhealth Uhealth Review BACKGROUND: Adherence to oral chemotherapy is crucial to maximize treatment outcomes and avoid health complications in cancer patients. Mobile phones are widely available worldwide, and evidence that this technology can be successfully employed to increase medication adherence for the treatment of other chronic diseases (eg, diabetes) is well established. However, the extent to which there is evidence that mobile phone–based interventions improve adherence to oral chemotherapy is unknown. OBJECTIVE: This scoping review aims to explore what is known about mobile phone–delivered interventions designed to enhance adherence to oral chemotherapy, to examine the reported findings on the utility of these interventions in increasing oral chemotherapy adherence, and to identify opportunities for development of future interventions. METHODS: This study followed Arksey and O’Malley’s scoping review methodological framework. RESULTS: The review search yielded 5 studies reporting on 4 interventions with adults (aged >18 years) diagnosed with diverse cancer types. All interventions were considered acceptable, useful, and feasible. The following themes were evident: text messages and mobile apps were the main methods of delivering these interventions, the 2 most commonly employed oral chemotherapy adherence–enhancing strategies were management and reporting of drug-related symptoms and reminders to take medication, the importance of stakeholders’ engagement in intervention design, and the overall positive perceptions of delivery features. Areas for future research identified by this review include the need for further studies to evaluate the impact of mobile phone–delivered interventions on adherence to oral chemotherapy as well as the relevance for future studies to incorporate design frameworks and economic evaluations and to explore the moderator effect of high anxiety, poor baseline adherence, and longer time taking prescribed drug on adherence to oral chemotherapy. CONCLUSIONS: Despite the increasing body of evidence on the use of mobile phones to deliver medication adherence–enhancing interventions in chronic diseases, literature on the oral chemotherapy context is lacking. This review showed that existing interventions are highly acceptable and useful to cancer patients. The engagement of stakeholders as well as the use of a design framework are important elements in the development of mobile phone–delivered interventions that can be translated into oncology settings. JMIR Publications 2018-12-21 /pmc/articles/PMC6320412/ /pubmed/30578182 http://dx.doi.org/10.2196/11724 Text en ©Xiomara Skrabal Ross, Kate M Gunn, Pandora Patterson, Ian Olver. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 21.12.2018. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Review
Skrabal Ross, Xiomara
Gunn, Kate M
Patterson, Pandora
Olver, Ian
Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title_full Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title_fullStr Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title_full_unstemmed Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title_short Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
title_sort mobile-based oral chemotherapy adherence–enhancing interventions: scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320412/
https://www.ncbi.nlm.nih.gov/pubmed/30578182
http://dx.doi.org/10.2196/11724
work_keys_str_mv AT skrabalrossxiomara mobilebasedoralchemotherapyadherenceenhancinginterventionsscopingreview
AT gunnkatem mobilebasedoralchemotherapyadherenceenhancinginterventionsscopingreview
AT pattersonpandora mobilebasedoralchemotherapyadherenceenhancinginterventionsscopingreview
AT olverian mobilebasedoralchemotherapyadherenceenhancinginterventionsscopingreview